Inspirational biotech leader with extensive global and local experience focused in cellular therapy, hematology and oncology. A results-oriented visionary able to successfully transform vision into strategy and aligned excellence in tactical execution. Proven success designing and developing novel commercial models, launching transformative medicines in multiple disease areas and exceeding inline expectations through innovation and collaboration. An empowering leader with an outstanding ability to build, lead and develop high performing teams.
Chief Executive Officer and Managing Director at Chimeric Therapeutics ASX: CHM
Biomedical Ethics